Keywords: پت اینترفرون; Allogeneic hematopoietic stem cell transplantation; Bortezomib; Donor lymphocytes; Durable remission; Mantle cell lymphoma; PEG-interferon;
مقالات ISI پت اینترفرون (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications
Keywords: پت اینترفرون; ANRS CirVir; HCV Clearance; Direct Antivirals; Prognosis; AFP; α-fetoprotein; ANRS CO12 CirVir; Agence Nationale pour la Recherche sur le SIDA et les hépatites virales cohort 12 viral cirrhosis; BI; bacterial infection; CumI; cumulated incidence; DAA; d
Liver, Pancreas and Biliary TractDual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication?
Keywords: پت اینترفرون; Cirrhosis; Hepatitis C virus; IL28B polymorphisms; Iron liver overload; Peg-interferon; Ribavirin; Sustained virological response; Thalassemia major;
New treatment for hepatitis C in chronic kidney disease, dialysis, and transplant
Keywords: پت اینترفرون; chronic kidney disease; dialysis; direct-acting antivirals; hepatitis C; peg-interferon; renal transplant; ribavirin;
Adherence to ribavirin in chronic hepatitis C patients on antiviral treatment: Results from a randomized controlled trial using real-time medication monitoring
Keywords: پت اینترفرون; CHC; chronic hepatitis C; SMS; Short Message Service; RTMM; real-time medication monitoring; HCV; hepatitis C virus; SVR; sustained virologic response; PEG-interferon; pegylated interferon; AE; adverse event; EVR; early virologic response; WBC; white bloo
Research ArticleIdentification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavirin
Keywords: پت اینترفرون; HCV; Chronic HCV liver disease; Peg-interferon; Ribavirin; Predictors of response;
Liver, Pancreas and Biliary TractPersonalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C
Keywords: پت اینترفرون; Boceprevir; Cost-effectiveness; Peg-interferon;
The E genotype of hepatitis B: Clinical and virological characteristics, and response to interferon
Keywords: پت اینترفرون; HBV; E genotype; PEG-interferon; Serological response; Virological responseHBV, Hepatitis B virus; HCC, hepatocellular carcinoma; NA, nucleos(t)ide analogues; CHB, chronic hepatitis B; PEG-INF, pegylated interferon; HBsAg, hepatitis B surface antigen; ALT
The effects of a maintenance therapy with peg-interferon alpha-2a on liver fibrosis in HIV/HCV co-infected patients: A randomized controlled trial
Keywords: پت اینترفرون; HIV/HCV co-infection; Liver fibrosis; Metavir fibrosis score; Peg-interferon; Randomized controlled trial
Antiviral therapy and fibrosis progression in patients with mild–moderate hepatitis C recurrence after liver transplantation. A randomized controlled study
Keywords: پت اینترفرون; HCV; PEG-Interferon; Recurrent hepatitis; Ribavirin
Quantification de l'AgHBs : nouvel outil virologique pour la prise en charge de l'hépatite B chronique
Keywords: پت اینترفرون; Hépatite B chronique; quantification; antigène HBs; ADN du VHB; prédiction de la réponse au traitement; interféron pégylé; analogues nucléo(t)siques; Chronic hepatitis B; quantitative assay; HBs antigen; HBV DNA; prediction of treatment response;
Evaluation of prognostic factors for Peg Interferon alfa-2b plus ribavirin treatment on HCV infected patients in Pakistan
Keywords: پت اینترفرون; HCV; PEG-interferon; SVR; RVR; Pakistan; ALT;
Ribavirin for chronic hepatitis C: And the mystery goes on
Keywords: پت اینترفرون; Peg-interferon; HCV; Mechanism of action; Combination therapy; Dose
Pegylated IFN-α2a combined to imatinib mesylate 600 mg daily can induce complete cytogenetic and molecular responses in a subset of chronic phase CML patients refractory to IFN alone or to imatinib 600 mg daily alone
Keywords: پت اینترفرون; CML; Imatinib resistance; Peg-Interferon; Philadelphia chromosome; BCR-ABL; BCR-ABL mutations
Research ArticlePre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors
Keywords: پت اینترفرون; IL28B; ISDR; Peg-interferon; Ribavirin; Data mining; Decision tree;
Research ArticleIndividualized treatment with combination of Peg-interferon alpha 2b and ribavirin in patients infected with HCV genotype 3
Keywords: پت اینترفرون; HCV genotype 3; Ribavirin; Peg-interferon; Short treatment;
No beneficial effects of amantadine in treatment of chronic hepatitis C patients
Keywords: پت اینترفرون; Amantadine; Hepatitis C; PEG-interferon; Ribavirin
Pegylated interferon and ribavirin in re-treatment of responder-relapser HCV patients
Keywords: پت اینترفرون; Chronic hepatitis C; PEG-Interferon; Relapsers; Ribavirin
Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension: A randomized controlled trial
Keywords: پت اینترفرون; Hepatitis C virus; Cirrhosis; Antiviral therapy; Peg-interferon; Ribavirin; Portal hypertension; Clinical course; Disease complications
The effect of pegylated interferon-α on the treatment of lamivudine resistant chronic HBeAg positive hepatitis B virus infection
Keywords: پت اینترفرون; Lamivudine; PEG-interferon; Hepatitis B virus; Resistance; YMDD; HBeAg positive;
Does depression symptomatology affect medication compliance during the first weeks of anti-HCV therapy in intravenous drug users?
Keywords: پت اینترفرون; Depression; HCV infection; Intravenous drug user; Peg-interferon; Treatment adherence
Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study
Keywords: پت اینترفرون; Hepatitis C virus; Peg-interferon; Ribavirin; Mixed cryoglobulinemia; Vasculitis;